androstenedione has been researched along with Glucose Intolerance in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adaway, J; Keevil, B; Lerchbaum, E; Lindheim, L; Münzker, J; Obermayer-Pietsch, B; Pieber, TR; Trummer, C | 1 |
Bayraktar, M; Oguz, H; Yarali, H; Yildiz, BO | 1 |
Cacciari, M; Gambineri, A; Manicardi, E; Morselli-Labate, AM; Pagotto, U; Pasquali, R; Pelusi, C; Vicennati, V | 1 |
3 other study(ies) available for androstenedione and Glucose Intolerance
Article | Year |
---|---|
High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Anovulation; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Glucose Intolerance; Humans; Insulin Resistance; Metabolic Diseases; Metabolic Syndrome; Phenotype; Polycystic Ovary Syndrome; Saliva; Tandem Mass Spectrometry; Testosterone | 2017 |
Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Constitution; Body Mass Index; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Female; Follicle Stimulating Hormone; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Luteinizing Hormone; Male; Menopause; Middle Aged; Mothers; Polycystic Ovary Syndrome; Siblings; Testosterone | 2003 |
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.
Topics: Adolescent; Adult; Androstenedione; Blood Glucose; Cohort Studies; Cosyntropin; Diabetes Mellitus; Diabetes Mellitus, Type 2; Family Health; Feeding Behavior; Female; Glucose Intolerance; Humans; Hydrocortisone; Insulin; Insulin Resistance; Mediterranean Region; Obesity; Phenotype; Physical Fitness; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 2004 |